A new study from Case Western Reserve University School of Medicine reveals that popular GLP-1 drugs for treating diabetes or prescribed for weight loss purposes, such as Wegovy and Ozempic, may significantly reduce alcohol misuse and alcohol use disorder
Clinical trials show tirzepatide produces greater average weight loss than semaglutide at comparable doses
Litigation Up-Date Goza & Honnold is working alongside other law firms in a coordinated effort to represent claimants who have experienced adverse side effects from semaglutide/weight loss drugs
it tells them they are safe, secure, and in their own territory
The FDA cautions that Wegovy carries the risk of such side effects as nausea, diarrhea, constipation, and vomiting
Some vendors operate domestically (US, EU) and charge more for local handling and faster shipping